Hear why Merck KGaA and INBRAIN Neurolectronics see such great promise in Bioelectronic medicine episode artwork

EPISODE · Jul 23, 2021 · 42 MIN

Hear why Merck KGaA and INBRAIN Neurolectronics see such great promise in Bioelectronic medicine

from DeviceTalks Podcast Network · host DeviceTalks Podcast Network

The bioelectronics industry is poised to take off so we visited with Carolina Aguilar, CEO/Co-founder, INBRAIN Neuroelectronics about the field's potential. Chris Newmarker, executive editor of life sciences at MassDevice, delivers his Newmarker's Newsmakers highlighting news from Dexcom, NeuroMetrix, Nevro, Ancora and the Galien foundation. Subscribe to this podcast on Google, Amazon, Apple, Spotify and other major podcast channels.

Episode metadata supplied by the publisher feed · Published Jul 23, 2021

Embed this episode

NOW PLAYING

Hear why Merck KGaA and INBRAIN Neurolectronics see such great promise in Bioelectronic medicine

0:00 42:16

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of DeviceTalks Podcast Network?

This episode is 42 minutes long.

When was this DeviceTalks Podcast Network episode published?

This episode was published on July 23, 2021.

Can I download this DeviceTalks Podcast Network episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!